genome Latest News

Leading physicians to guide Paradigm’s molecular diagnostic testing to ensure quality and the best-in-class patient care.

Two breakout discussion groups have been announced at CHI’s Bioinformatics in the Genome Era conference to be held on February 13-15, 2013 at the Moscone in San Francisco, CA. This conference is part of the Molecular Med TRI-CON 2013.

Genome Designs, genome annotation and metabolic modelling service provider, today announced a partnership with SciDM Group, a bioinformatics tools developer. The company will be using SciDM’s high performance database engine and other technologies.

Pathogenica has extended a Cooperative Research Agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). USAMRIID had success using Pathogenica’s platform to detect exotic viruses.

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

Christopher P. Austin, M.D., Scientific Director, NIH Center for Translational Therapeutics, will deliver the keynote presentation at CHI’s Predictive Functional Human Tissue Models conference scheduled on November 17-18, 2011, Boston, MA.

Hear talks on NGS Data Management, and the impact of Sequencing on personalized medicine. This conference will take place on September 26-28, 2011 in Providence, RI. Early registration discounts will be offered until July 29.

Leading physicians to guide Paradigm’s molecular diagnostic testing to ensure quality and the best-in-class patient care.

Drugging the Undruggable: Transforming Nature’s α-Helix into Breakthrough Medicines will be discussed at CHI's 13th Annual Structure-Based Drug Design Conference this coming...

Two breakout discussion groups have been announced at CHI’s Bioinformatics in the Genome Era conference to be held on February 13-15, 2013 at the Moscone in San Francisco, CA. This conference is part of the Molecular Med TRI-CON 2013.

“Now that we have the genome sequence, we can kick start the development of genetic tools for Setaria.”

A Three Day Event Focusing on the Challenges in Next-Generation Sequencing

A Three Day Event Focusing on the Challenges in NGS Data Analysis

Genome Designs, genome annotation and metabolic modelling service provider, today announced a partnership with SciDM Group, a bioinformatics tools developer. The company will be using SciDM’s high performance database engine and other technologies.

Pathogenica has extended a Cooperative Research Agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). USAMRIID had success using Pathogenica’s platform to detect exotic viruses.

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

NGS Leaders community to host industry discussion on key challenge of next-generation sequencing data

Navigating the Future of Genomic Technologies. March 5-8, 2012 at the Hilton San Diego Resort

Christopher P. Austin, M.D., Scientific Director, NIH Center for Translational Therapeutics, will deliver the keynote presentation at CHI’s Predictive Functional Human Tissue Models conference scheduled on November 17-18, 2011, Boston, MA.

Technology development in the life sciences sector received a much-needed boost with the announcement of five projects funded through Genome BC’s Proof of Concept (POC) Program. The program promises close to $9M to accelerate...

Hear talks on NGS Data Management, and the impact of Sequencing on personalized medicine. This conference will take place on September 26-28, 2011 in Providence, RI. Early registration discounts will be offered until July 29.

Sengenics today announced the introduction of a new microarray based genetic diagnostics test into Asia. The microarray used for the test was designed by Oxford Gene Technology (OGT), UK in conjunction with Emory Genetics, USA.

Canadian scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes.

Sigma® Life Science and King's College London co-developing miRNA Target Identification Technology

“Rusts,” a group of fungi that attack and damage plants and trees, cost the international agriculture and forestry sectors billions of dollars in lost revenue every year, with an estimated loss of $200 million a year due to the destruction of...

Scientists have set a new standard for studying outbreaks of infectious disease by combining advanced genomics with a detailed map of the social relationships between cases to investigate a recent outbreak of tuberculosis in a BC community.

We are pleased to announce that we are changing our company name from PhyloTech to Second Genome.

The Alan and Priscilla Oppenheimer Foundation announced today that, in collaboration with the Personal Genome Project (PGP), it has begun the process of sequencing the first full human genome in the next major phase of that project, the PGP-1K.

Uncovering mutations found in deadly transmissible cancer could help conservation efforts

Second-Generation Applications to Third Generation Progress

Steve Sommer, M.D., Ph.D., president and founder of MEDomics LLC announces new test for mitochondrial diseases.

Knight Investments LLC recently supported the ARS Scientist successful sequencing of the parasite genome that is invading and killing local honey bees, in an effort to help solve the problems with pollination.

20 individuals to be among first in history to be fully sequenced